Evidence map›Paper›PMID 31100139›Full record

ArticleThe Gerontologist2019

Complex Multimorbidity and Breast Cancer Screening Among Midlife and Older Women: The Role of Perceived Need.

David F Warner, Siran M Koroukian, Nicholas K Schiltz, Kathleen A Smyth, Gregory S Cooper, Cynthia Owusu, Kurt C Stange, Nathan A Berger

Abstract read
In one paragraph

Article in The Gerontologist, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Women's experiences of age-related discontinuation from mammography screening: A qualitative interview study.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David F WarnerDepartment of Sociology, University of Nebraska-Lincoln.
Siran M KoroukianDepartment of Population and Quantitative Health Sciences.
Nicholas K SchiltzDepartment of Population and Quantitative Health Sciences.
Kathleen A SmythDepartment of Population and Quantitative Health Sciences.
Gregory S CooperCase Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Cynthia OwusuCase Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Kurt C StangeCase Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Nathan A BergerCase Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio.

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
Prevention Research Center for Healthy NeighborhoodsU48DP005030 · DP · CASE WESTERN RESERVE UNIVERSITY · PI BORAWSKI, ELAINE A. · 2014 to 2018
$6.8M
Reducing Functional Health Disparities among Older Breast Cancer SurvivorsR01MD009699 · NIMHD · CASE WESTERN RESERVE UNIVERSITY · PI OWUSU, CYNTHIA · 2015 to 2019
$2.8M
Research Development CoreR24HD050959 · NICHD · BOWLING GREEN STATE UNIVERSITY · PI BALISTRERI, KELLY STAMPER · 2005 to 2016
$2.6M
NCCDPHP CDC HHS U48 DP005030NCI NIH HHS P30 CA043703NICHD NIH HHS R24 HD050959
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThere is minimal survival benefit to cancer screening for those with poor clinical presentation (complex multimorbidity) or at advanced ages. The current screening mammography guidelines consider these objective indicators. There has been less attention, however, to women's subjective assessment of screening need. This study examines the interplay between complex multimorbidity, age, and subjective assessments of health and longevity for screening mammography receipt. RESEARCH DESIGN AND

methodThis cross-sectional study uses self-reported data from 8,938 women over the age of 52 in the 2012 Health and Retirement Study. Logistic regression models estimated the association between women's complex multimorbidity (co-occurrence of chronic conditions, functional limitations, and/or geriatric syndromes), subjective health and longevity assessments, age, and screening mammography in the 2 years before the interview. These associations were evaluated adjusting for sociodemographic and behavioral factors.

resultsBoth age and complex multimorbidity were negatively associated with screening mammography. However, women's perceived need for screening moderated these effects. Most significantly, women optimistic about their chances of living another 10-15 years were more likely to have had screening mammography regardless of their health conditions or advanced age. DISCUSSION AND IMPLICATIONS: Women with more favorable self-assessed health and perceived life expectancy were more likely to receive screening mammography even if they have poor clinical presentation or advanced age. This is contrary to current cancer screening guidelines and suggests an opportunity to engage women's subjective health and longevity assessments for cancer screening decision making in both for screening policy and in individual clinician recommendations.

Indexed as

Early Detection of CancerMammographyMultimorbidityAgedBreast NeoplasmsCross-Sectional StudiesDecision MakingFemaleHumansInterviews as TopicLogistic ModelsMiddle AgedDecision makingMammographyPerceived life expectancySubjective health

Identifiers

PMID31100139
PMCPMC6524759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.